141 related articles for article (PubMed ID: 37339719)
1. Design and synthesis of aminopyridine containing biaryls reducing c-MYC protein levels in cells.
Di Marco CN; Terrell L; Sanchez R; Rueda L; Shuster L; Nartey EN; McHugh C; Mack JF; Shu A; Tian X; Medina JR; Rivero R; Manetsch R; Heerding D; Mangatt B
Bioorg Med Chem Lett; 2023 Aug; 92():129385. PubMed ID: 37339719
[TBL] [Abstract][Full Text] [Related]
2. Translocations involving c-myc and c-myc function.
Boxer LM; Dang CV
Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
[TBL] [Abstract][Full Text] [Related]
3. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?
Mol PC; Wang RH; Batey DW; Lee LA; Dang CV; Berger SL
Mol Cell Biol; 1995 Dec; 15(12):6999-7009. PubMed ID: 8524267
[TBL] [Abstract][Full Text] [Related]
4. Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation.
Tamura K; Hua B; Adachi S; Guney I; Kawauchi J; Morioka M; Tamamori-Adachi M; Tanaka Y; Nakabeppu Y; Sunamori M; Sedivy JM; Kitajima S
EMBO J; 2005 Jul; 24(14):2590-601. PubMed ID: 15990869
[TBL] [Abstract][Full Text] [Related]
5. c-Myc-regulated microRNAs modulate E2F1 expression.
O'Donnell KA; Wentzel EA; Zeller KI; Dang CV; Mendell JT
Nature; 2005 Jun; 435(7043):839-43. PubMed ID: 15944709
[TBL] [Abstract][Full Text] [Related]
6. HMG-I/Y, a new c-Myc target gene and potential oncogene.
Wood LJ; Mukherjee M; Dolde CE; Xu Y; Maher JF; Bunton TE; Williams JB; Resar LM
Mol Cell Biol; 2000 Aug; 20(15):5490-502. PubMed ID: 10891489
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
8. The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.
Kumaraswamy A; Mamidi A; Desai P; Sivagnanam A; Perumalsamy LR; Ramakrishnan C; Gromiha M; Rajalingam K; Mahalingam S
J Biol Chem; 2018 Oct; 293(40):15691-15705. PubMed ID: 30139745
[No Abstract] [Full Text] [Related]
9. Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells.
Hoffman-Liebermann B; Liebermann DA
Oncogene; 1991 Jun; 6(6):903-9. PubMed ID: 1906157
[TBL] [Abstract][Full Text] [Related]
10. Cell-Based Drug Discovery: Identification and Optimization of Small Molecules that Reduce
Medina JR; Tian X; Li WH; Suarez D; Mack JF; LaFrance L; Martyr C; Brackley J; Di Marco C; Rivero R; Heerding DA; McHugh C; Minthorn E; Bhaskar A; Rubin J; Butticello M; Carpenter C; Nartey EN; Berrodin TJ; Kallal LA; Mangatt B
J Med Chem; 2021 Nov; 64(21):16056-16087. PubMed ID: 34669409
[TBL] [Abstract][Full Text] [Related]
11. Polyamine-modulated expression of c-myc plays a critical role in stimulation of normal intestinal epithelial cell proliferation.
Liu L; Li L; Rao JN; Zou T; Zhang HM; Boneva D; Bernard MS; Wang JY
Am J Physiol Cell Physiol; 2005 Jan; 288(1):C89-99. PubMed ID: 15355849
[TBL] [Abstract][Full Text] [Related]
12. Function of the c-Myc oncogenic transcription factor.
Dang CV; Resar LM; Emison E; Kim S; Li Q; Prescott JE; Wonsey D; Zeller K
Exp Cell Res; 1999 Nov; 253(1):63-77. PubMed ID: 10579912
[TBL] [Abstract][Full Text] [Related]
13. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
Alexandrow MG; Moses HL
J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
[TBL] [Abstract][Full Text] [Related]
14. Myc/Max/Mad regulate the frequency but not the duration of productive cell cycles.
Hölzel M; Kohlhuber F; Schlosser I; Hölzel D; Lüscher B; Eick D
EMBO Rep; 2001 Dec; 2(12):1125-32. PubMed ID: 11743027
[TBL] [Abstract][Full Text] [Related]
15. Cyclin A links c-Myc to adhesion-independent cell proliferation.
Barrett JF; Lewis BC; Hoang AT; Alvarez RJ; Dang CV
J Biol Chem; 1995 Jul; 270(27):15923-5. PubMed ID: 7608142
[TBL] [Abstract][Full Text] [Related]
16. JQ1 and PI3K inhibition synergistically reduce salivary adenoid cystic carcinoma malignancy by targeting the c-Myc and EGFR signaling pathways.
Liu X; Wu H; Huang P; Zhang F
J Oral Pathol Med; 2019 Jan; 48(1):43-51. PubMed ID: 30269363
[TBL] [Abstract][Full Text] [Related]
17. Cell-cycle progression is not essential for c-Myc to block differentiation.
Ryan KM; Birnie GD
Oncogene; 1997 Jun; 14(23):2835-43. PubMed ID: 9190900
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest?
Bennett MR; Littlewood TD; Hancock DC; Evan GI; Newby AC
Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):701-8. PubMed ID: 7524476
[TBL] [Abstract][Full Text] [Related]
19. Polyamine-modulated c-Myc expression in normal intestinal epithelial cells regulates p21Cip1 transcription through a proximal promoter region.
Liu L; Guo X; Rao JN; Zou T; Marasa BS; Chen J; Greenspon J; Casero RA; Wang JY
Biochem J; 2006 Sep; 398(2):257-67. PubMed ID: 16706751
[TBL] [Abstract][Full Text] [Related]
20. The Max b-HLH-LZ can transduce into cells and inhibit c-Myc transcriptional activities.
Montagne M; Beaudoin N; Fortin D; Lavoie CL; Klinck R; Lavigne P
PLoS One; 2012; 7(2):e32172. PubMed ID: 22384171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
